ArticleBritish journal of haematology2026
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myeloma.
Elizabeth Hughes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it